IgE-话题@MedSci

#IgE#

86篇内容 | 2930人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1426369, encodeId=3355142636947, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=肿瘤个性化治疗——肿瘤新抗原Neoantigen疗法首次获批进入临床试验, objectType=article, longId=158976, objectId=44f21589e6dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44f21589e6dd, replyNumber=0, likeNumber=0, createdTime=2019-01-28, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44f21589e6dd, moduleTitle=肿瘤个性化治疗——肿瘤新抗原Neoantigen疗法首次获批进入临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=44f21589e6dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426368, encodeId=2a9b1426368f9, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=Epigenetics Chromatin：研究揭示TET1和TET2在调节间充质细胞分化中的特定功能, objectType=article, longId=157648, objectId=acde15e64805, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=acde15e64805, replyNumber=0, likeNumber=69, createdTime=2019-01-10, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=acde15e64805, moduleTitle=Epigenetics Chromatin：研究揭示TET1和TET2在调节间充质细胞分化中的特定功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=acde15e64805)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426367, encodeId=1d3c142636e5f, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=Digestive Dis Sci： CEGP-003喷雾剂对于治疗急性上消化道出血患者具有与肾上腺素同样的止血效果, objectType=article, longId=153957, objectId=a3fd15395e4b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3fd15395e4b, replyNumber=0, likeNumber=72, createdTime=2018-11-21, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3fd15395e4b, moduleTitle=Digestive Dis Sci： CEGP-003喷雾剂对于治疗急性上消化道出血患者具有与肾上腺素同样的止血效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3fd15395e4b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426366, encodeId=ca001426366a6, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=Digestive Dis Sci：静脉输注铁羧酸麦芽糖相比于口服铁制剂对于改善胃肠道相关缺铁性贫血效果更好, objectType=article, longId=153956, objectId=4beb15395673, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4beb15395673, replyNumber=0, likeNumber=82, createdTime=2018-11-21, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4beb15395673, moduleTitle=Digestive Dis Sci：静脉输注铁羧酸麦芽糖相比于口服铁制剂对于改善胃肠道相关缺铁性贫血效果更好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4beb15395673)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426365, encodeId=66a5142636549, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=Niger Postgrad Med J：德莱曼综合症病例报告及治疗, objectType=article, longId=151372, objectId=36d91513e259, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36d91513e259, replyNumber=0, likeNumber=70, createdTime=2018-10-20, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36d91513e259, moduleTitle=Niger Postgrad Med J：德莱曼综合症病例报告及治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36d91513e259)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426364, encodeId=6521142636457, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=Digestive Surgery：术前营养优化可以改善克罗恩病患者的手术结果, objectType=article, longId=149105, objectId=727c14910590, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=727c14910590, replyNumber=0, likeNumber=0, createdTime=2018-09-20, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=727c14910590, moduleTitle=Digestive Surgery：术前营养优化可以改善克罗恩病患者的手术结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=727c14910590)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426363, encodeId=c9b9142636357, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=《柳叶刀》发表了Kyowa Hakko ''s Poteligeo的PhIII数据, objectType=article, longId=146771, objectId=bd23146e7143, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd23146e7143, replyNumber=0, likeNumber=59, createdTime=2018-08-18, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd23146e7143, moduleTitle=《柳叶刀》发表了Kyowa Hakko ''s Poteligeo的PhIII数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd23146e7143)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426362, encodeId=1dc2142636248, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=柳叶刀公布了Kyowa Kirin公司CCR4单抗Poteligeo 治疗皮肤T细胞淋巴瘤的III期临床数据, objectType=article, longId=146735, objectId=31ee146e35d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31ee146e35d9, replyNumber=0, likeNumber=129, createdTime=2018-08-17, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31ee146e35d9, moduleTitle=柳叶刀公布了Kyowa Kirin公司CCR4单抗Poteligeo 治疗皮肤T细胞淋巴瘤的III期临床数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31ee146e35d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426361, encodeId=dc1a142636160, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=FDA授予IgE单抗Xolair突破性疗法认定，治疗食物过敏, objectType=article, longId=146617, objectId=039914661e80, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=039914661e80, replyNumber=0, likeNumber=83, createdTime=2018-08-16, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=039914661e80, moduleTitle=FDA授予IgE单抗Xolair突破性疗法认定，治疗食物过敏, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=039914661e80)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426360, encodeId=630f14263607c, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=基因编辑公司博雅辑因（EdiGene）宣布完成亿元Pre-B轮融资，礼来亚洲基金领投, objectType=article, longId=146539, objectId=e343146539ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e343146539ff, replyNumber=0, likeNumber=28, createdTime=2018-08-15, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e343146539ff, moduleTitle=基因编辑公司博雅辑因（EdiGene）宣布完成亿元Pre-B轮融资，礼来亚洲基金领投, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e343146539ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426359, encodeId=26ec142635978, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=FDA批准Kyowa Kirin的CCR4单抗Poteligeo 治疗皮肤淋巴瘤, objectType=article, longId=146284, objectId=5c1f146284f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c1f146284f1, replyNumber=0, likeNumber=58, createdTime=2018-08-11, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c1f146284f1, moduleTitle=FDA批准Kyowa Kirin的CCR4单抗Poteligeo 治疗皮肤淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c1f146284f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426358, encodeId=a972142635809, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=Eiger制药宣布首例患者入组聚乙二醇化干扰素联合Ritonavir-Boosted Lonafarnib的II期LIFT研究, objectType=article, longId=146130, objectId=8c0f14613063, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c0f14613063, replyNumber=0, likeNumber=81, createdTime=2018-08-09, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c0f14613063, moduleTitle=Eiger制药宣布首例患者入组聚乙二醇化干扰素联合Ritonavir-Boosted Lonafarnib的II期LIFT研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8c0f14613063)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426357, encodeId=4e51142635e37, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=Niger J Clin Pract：评估NO的呼出分数来诊断慢性咳嗽, objectType=article, longId=145462, objectId=a47f145462e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a47f145462e6, replyNumber=0, likeNumber=53, createdTime=2018-07-31, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a47f145462e6, moduleTitle=Niger J Clin Pract：评估NO的呼出分数来诊断慢性咳嗽, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a47f145462e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426356, encodeId=08fa1426356f7, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=J DIGEST DIS：注意！慢性丙型肝炎病毒清除后仍可患肝癌！, objectType=article, longId=142417, objectId=17fe14241ea2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17fe14241ea2, replyNumber=0, likeNumber=74, createdTime=2018-07-05, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17fe14241ea2, moduleTitle=J DIGEST DIS：注意！慢性丙型肝炎病毒清除后仍可患肝癌！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17fe14241ea2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426355, encodeId=8a34142635566, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=Epigenetics：组蛋白去甲基化酶KDM4B可抑制破骨细胞的生成, objectType=article, longId=141441, objectId=fba7141441d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fba7141441d2, replyNumber=0, likeNumber=41, createdTime=2018-06-25, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fba7141441d2, moduleTitle=Epigenetics：组蛋白去甲基化酶KDM4B可抑制破骨细胞的生成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fba7141441d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426354, encodeId=552b142635448, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=Clinical Epigenetics：新的表观遗传肿瘤治疗可能会影响后代吗？, objectType=article, longId=138680, objectId=1c0713868066, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c0713868066, replyNumber=0, likeNumber=66, createdTime=2018-05-22, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c0713868066, moduleTitle=Clinical Epigenetics：新的表观遗传肿瘤治疗可能会影响后代吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c0713868066)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426353, encodeId=aac014263530a, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=Rigel的Tavalisse获得FDA批准, objectType=article, longId=135810, objectId=21971358107f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21971358107f, replyNumber=0, likeNumber=49, createdTime=2018-04-20, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21971358107f, moduleTitle=Rigel的Tavalisse获得FDA批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=21971358107f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426352, encodeId=1d0f1426352b6, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=Niger J Clin Pract：使用NIDEK进行轴向长度扫描，分析白内障手术中的角膜散光变化, objectType=article, longId=134445, objectId=25c213444503, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25c213444503, replyNumber=0, likeNumber=70, createdTime=2018-04-08, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25c213444503, moduleTitle=Niger J Clin Pract：使用NIDEK进行轴向长度扫描，分析白内障手术中的角膜散光变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25c213444503)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426351, encodeId=7081142635142, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=Niger J Clin Pract：尼日利亚西北部医生对糖尿病视网膜病变的认识、态度和实际情况调查, objectType=article, longId=134444, objectId=10eb1344440f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10eb1344440f, replyNumber=0, likeNumber=0, createdTime=2018-04-08, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10eb1344440f, moduleTitle=Niger J Clin Pract：尼日利亚西北部医生对糖尿病视网膜病变的认识、态度和实际情况调查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=10eb1344440f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426350, encodeId=ac1e1426350e9, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=我国Meige综合征诊断和治疗专家共识（2018年）, objectType=article, longId=129934, objectId=94c1129934be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=94c1129934be, replyNumber=0, likeNumber=30, createdTime=2018-02-15, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94c1129934be, moduleTitle=我国Meige综合征诊断和治疗专家共识（2018年）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=94c1129934be)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

IgE

2020-05-29

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

肿瘤个性化治疗——肿瘤新抗原Neoantigen疗法首次获批进入临床试验

2019-01-28

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

Epigenetics Chromatin：研究揭示TET1和TET2在调节间充质细胞分化中的特定功能

2019-01-10

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

Digestive Dis Sci： CEGP-003喷雾剂对于治疗急性上消化道出血患者具有与肾上腺素同样的止血效果

2018-11-21

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

Digestive Dis Sci：静脉输注铁羧酸麦芽糖相比于口服铁制剂对于改善胃肠道相关缺铁性贫血效果更好

2018-11-21

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

Niger Postgrad Med J：德莱曼综合症病例报告及治疗

2018-10-20

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

Digestive Surgery：术前营养优化可以改善克罗恩病患者的手术结果

2018-09-20

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

《柳叶刀》发表了Kyowa Hakko ''s Poteligeo的PhIII数据

2018-08-18

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

柳叶刀公布了Kyowa Kirin公司CCR4单抗Poteligeo 治疗皮肤T细胞淋巴瘤的III期临床数据

2018-08-17

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

FDA授予IgE单抗Xolair突破性疗法认定，治疗食物过敏

2018-08-16

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

基因编辑公司博雅辑因（EdiGene）宣布完成亿元Pre-B轮融资，礼来亚洲基金领投

2018-08-15

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

FDA批准Kyowa Kirin的CCR4单抗Poteligeo 治疗皮肤淋巴瘤

2018-08-11

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

Eiger制药宣布首例患者入组聚乙二醇化干扰素联合Ritonavir-Boosted Lonafarnib的II期LIFT研究

2018-08-09

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

Niger J Clin Pract：评估NO的呼出分数来诊断慢性咳嗽

2018-07-31

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

J DIGEST DIS：注意！慢性丙型肝炎病毒清除后仍可患肝癌！

2018-07-05

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

Epigenetics：组蛋白去甲基化酶KDM4B可抑制破骨细胞的生成

2018-06-25

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

Clinical Epigenetics：新的表观遗传肿瘤治疗可能会影响后代吗？

2018-05-22

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

Rigel的Tavalisse获得FDA批准

2018-04-20

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

Niger J Clin Pract：使用NIDEK进行轴向长度扫描，分析白内障手术中的角膜散光变化

2018-04-08

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

Niger J Clin Pract：尼日利亚西北部医生对糖尿病视网膜病变的认识、态度和实际情况调查

2018-04-08

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

我国Meige综合征诊断和治疗专家共识（2018年）

2018-02-15

科室
- - 订阅+
  - 更多科室
工具
服务